Cervical cancer trial underway in Victoria

by Susi Hamilton
Cervical cancer trial underway in Victoria
HPV virus

As the government considers recommendations for changes to cervical cancer screening, UNSW is already a leading partner in a major trial of the new technology in Victoria.

The new Human Papillomavirus (HPV) testing regime that is being considered involves a five-year test, instead of the current two-yearly Pap . The technology was recently approved in the US and is being piloted in the UK.

"Many women find the experience of screening embarrassing and difficult, so they'll welcome the proposed changes, which would mean the number of tests they undergo over their lives drops from 26 to around 10," says UNSW Associate Professor Canfell, whose group performed the effectiveness and economic modelling that supported the .

If the new testing regime is introduced, it is expected that cervical cancer rates will be reduced by a further 15%, with up to 100 more women a year being spared a cervical cancer diagnosis and up to 30 more lives saved every year.

Compass is the first large-scale clinical trial internationally to compare Pap test screening with HPV screening in an HPV-vaccinated population.

In the first phase, 5,000 Victorian women will be recruited to the trial, which Associate Professor Canfell is co-leading with Associate Professor Marion Saville, Director of the Victorian Cytology Service.

"The Compass trial will give us a pragmatic, real-world experience of HPV testing," says Associate Professor Canfell. "The women who are volunteering for the trial are helping us set up all the systems for testing, if the recommendations are taken up."

"The piloting of a new screening technology involves a lot more than just implementing the in a laboratory," says Associate Professor Marion Saville. "This involves substantial changes to register operations and to information resources. It's very much about how to actually implement a new process of in this country."

The current Compass trial is expected to be rolled out to a larger trial of 100,000 women by the end of the year.

add to favorites email to friend print save as pdf

Related Stories

Longer screening intervals possible with HPV-based tests

Jan 21, 2014

A new study from Karolinska Institutet in Sweden finds that testing for human papilloma virus (HPV) allows for longer time between screening tests when compared to cytology-based testing. The study is published in the scientific ...

Too many Pap tests

Jul 26, 2013

Most Australian women are currently having more Pap smears than their health requires, according to new research led by a University of New South Wales academic.

FDA experts debate timing of pap test

Mar 12, 2014

(HealthDay)—The Pap test has been a routine gynecological procedure for generations of American women. But on Wednesday, a Food and Drug Administration advisory panel is considering whether to delay the ...

US OKs first-ever DNA alternative to Pap smear (Update 2)

Apr 24, 2014

U.S. government health regulators have cleared a genetic test from Roche as a first-choice screening option for cervical cancer. It was a role previously reserved for the Pap smear, the decades-old mainstay of women's health.

HPV testing could cut cervical cancers by a third

Jun 14, 2013

(Medical Xpress)—Testing women for the human papillomavirus (HPV) first, instead of using the traditional cervical screening test to detect abnormal cells in the cervix, could prevent around 600 cases of ...

Recommended for you

New paper describes how DNA avoids damage from UV light

13 hours ago

In the same week that the U.S. surgeon general issued a 101-page report about the dangers of skin cancer, researchers at Montana State University published a paper breaking new ground on how DNA – the genetic code in every ...

Drug target identified for common childhood blood cancer

14 hours ago

In what is believed to be the largest genetic analysis of what triggers and propels progression of tumor growth in a common childhood blood cancer, researchers at NYU Langone Medical Center report that they have identified ...

User comments